These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 29625272)

  • 1. Reporting bias in completed epilepsy intervention trials: A cross-sectional analysis.
    Rayi A; Thompson S; Gloss D; Malhotra K
    Epilepsy Res; 2018 Jul; 143():1-6. PubMed ID: 29625272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Registration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study.
    Zou CX; Becker JE; Phillips AT; Garritano JM; Krumholz HM; Miller JE; Ross JS
    Trials; 2018 Oct; 19(1):581. PubMed ID: 30352601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reporting Compliance of Stroke Trials: Cross-Sectional Analysis.
    Malhotra K; Rayi A; Khunger M; Thompson S; Liebeskind DS
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1472-1480. PubMed ID: 28412315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study.
    DeVito NJ; Bacon S; Goldacre B
    Lancet; 2020 Feb; 395(10221):361-369. PubMed ID: 31958402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012.
    Miller JE; Korn D; Ross JS
    BMJ Open; 2015 Nov; 5(11):e009758. PubMed ID: 26563214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance with results reporting at ClinicalTrials.gov.
    Anderson ML; Chiswell K; Peterson ED; Tasneem A; Topping J; Califf RM
    N Engl J Med; 2015 Mar; 372(11):1031-9. PubMed ID: 25760355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance on Mandatory Data Reporting in Registered Obstetrics Trials.
    Checketts JX; Evans MB; Athale AH; Jawhar OM; Wright MR; Bryant K; Vassar M
    Am J Perinatol; 2018 Oct; 35(12):1192-1196. PubMed ID: 29695018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study.
    Prayle AP; Hurley MN; Smyth AR
    BMJ; 2012 Jan; 344():d7373. PubMed ID: 22214756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten Years after the International Committee of Medical Journal Editors' Clinical Trial Registration Initiative, One Quarter of Phase 3 Pediatric Epilepsy Clinical Trials Still Remain Unpublished: A Cross Sectional Analysis.
    Lampert A; Hoffmann GF; Ries M
    PLoS One; 2016; 11(1):e0144973. PubMed ID: 26735955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating publication bias for clinical trials supporting new dermatologic drug approvals from 2003 to 2018.
    Ravichandran S; Mulligan KM; Ezaldein HH; Scott JF
    Arch Dermatol Res; 2023 May; 315(4):831-838. PubMed ID: 36333459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with reporting results for pulmonary clinical trials in ClinicalTrials.gov.
    Riley IL; Boulware LE; Sun JL; Chiswell K; Que LG; Kraft M; Todd JL; Palmer SM; Anderson ML
    Clin Trials; 2018 Feb; 15(1):87-94. PubMed ID: 29121787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the FDA Amendment Act with trial registration, publication, and outcome reporting.
    Phillips AT; Desai NR; Krumholz HM; Zou CX; Miller JE; Ross JS
    Trials; 2017 Jul; 18(1):333. PubMed ID: 28720112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial reporting performance of thirty UK universities on ClinicalTrials.gov-evaluation of a new tracking tool for the US clinical trial registry.
    Keestra SM; Rodgers F; Lenz D; Osborne R; Bruckner T; Lee S
    Trials; 2021 Jun; 22(1):375. PubMed ID: 34074329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public availability of results of trials assessing cancer drugs in the United States.
    Nguyen TA; Dechartres A; Belgherbi S; Ravaud P
    J Clin Oncol; 2013 Aug; 31(24):2998-3003. PubMed ID: 23878298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consistency of trial reporting between ClinicalTrials.gov and corresponding publications: one decade after FDAAA.
    Talebi R; Redberg RF; Ross JS
    Trials; 2020 Jul; 21(1):675. PubMed ID: 32703252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reporting Bias in Clinical Trials Investigating the Efficacy of Second-Generation Antidepressants in the Treatment of Anxiety Disorders: A Report of 2 Meta-analyses.
    Roest AM; de Jonge P; Williams CD; de Vries YA; Schoevers RA; Turner EH
    JAMA Psychiatry; 2015 May; 72(5):500-10. PubMed ID: 25806940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The fate of prospective spine studies registered on www.ClinicalTrials.gov.
    Ohnmeiss DD
    Spine J; 2015 Mar; 15(3):487-91. PubMed ID: 25315132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes to registration elements and results in a cohort of Clinicaltrials.gov trials were not reflected in published articles.
    Pranić S; Marušić A
    J Clin Epidemiol; 2016 Feb; 70():26-37. PubMed ID: 26226103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial transparency: a reassessment of industry compliance with clinical trial registration and reporting requirements in the United States.
    Lassman SM; Shopshear OM; Jazic I; Ulrich J; Francer J
    BMJ Open; 2017 Sep; 7(9):e015110. PubMed ID: 28942418
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.